Liposome Adjuvants: Simultaneous Induction of Innate and Adaptive Immunity is Key to Success
Journal Title: Journal of Vaccines and Immunology - Year 2015, Vol 1, Issue 1
Abstract
The current generation vaccines are mainly composed of highly purified antigens and tend to be poorly immunogenic, requiring potent adjuvants for their success. The adjuvants currently available suffer from various drawbacks such as low potency (inability to activate strong humoral and cell-mediated immune response) and extreme toxicity for routine clinical use in humans. In addition, not all adjuvants are effective for all antigens. The compromise between the requirement for strong adjuvant activity and an acceptable low level of toxicity has left us with limited choice of adjuvants. Although alum adjuvant has been used for decades, it is associated with severe local reaction and is unable to activate cell-mediated immunity, hence has proven unsuccessful against intracellular infections [1 1. Gupta RK, Relyveld EH, Lindblad EB, Bizzini B, Ben-Efraim S, et al. (1993) Adjuvants--a balance between toxicity and adjuvanticity. Vaccine 11: 293-306. ]. Therefore, it is very important to identify new adjuvants or improve the existing ones. The ideal adjuvant would be one that apart from activating strong humoral and cell-mediated immune response, has negligible toxicity to the host.
Authors and Affiliations
Faisal Syed M
Keywords
Related Articles
- EP ID EP553519
- DOI 10.17352/jvi.000004
- Views 55
- Downloads 0
Preparation and Application of two Monoclonal Antibodies against Canine Parvovirus Vaccine and Field Strains
Background: Canine parvovirus (CPV) emerged in 1970s as a highly infectious disease. CPV modified live vaccines have been widely used to control the disease. It is urgent to develop specific monoclonal antibodies to diff...
Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus
Background: Newcastle disease virus (NDV) genotype VII has become the dominant genotype in China. However, NDV genotype II was used to make current commercial NDV vaccines. The mismatch of genotypes between circulating a...
Pathogenicity of Duck-Originated H9N2 Influenza Viruses on Chickens
Background: The spreading of H9N2 avian influenza viruses in poultry in Eurasia and Africa accompanied with the great economic losses to poultry industry in past decades has attracted the great attention of whole world....
Safety of the Novel Vector Vaccine Against Brucella Abortus Based on Recombinant Influenza Viruses Expressing Brucella L7/L12 and OMP16 Proteins, in Cattle
This paper presents the results of a study of the safety of new vector vaccine against B. abortus based on recombinant influenza A subtype H5N1 or H1N1 (viral constructs vaccine formulation) viruses expressing Brucella r...
Immunogenicity of Hydrolysate Formulas in Children (Part 1). Review of 202 Reactions
Cow's milk (CM) protein hydrolyzed formulas (HFs) appeared in the 40's with the aim of decreasing or eliminating the allergenicity of CM proteins, and in addition of reducing the risk of sensitization. In recent years th...